Your Web News in One Place

Help Webnuz

Referal links:

Sign up for GreenGeeks web hosting
June 15, 2020 04:58 pm

FDA ends emergency authorization for hydroxychloroquine


US-HEALTH-VIRUS-MEDICINE

Photo by GEORGE FREY/AFP via Getty Images

The Food and Drug Administration is withdrawing emergency authorization for chloroquine and hydroxychloroquine as treatments for COVID-19, the agency announced today. Recent clinical trials showed that the drugs were not effective against the disease.


The medications are still FDA-approved for diseases like malaria and lupus, so they remain on the market. Because they are approved for other diseases, doctors could technically still prescribe them for COVID-19 patients under off-label use. Clinical trials focusing on the drugs can also continue. This decision, though, indicates that the FDA is no longer confident that the drug would benefit COVID-19 patients.


“We now believe that the suggested dosing regimens for [chloroquine] and...



Continue reading…




Original Link: https://www.theverge.com/2020/6/15/21291694/fda-hydroxychloroquine-emergency-authorization-trump-barda

Share this article:    Share on Facebook
View Full Article

The Verge

The Verge is an ambitious multimedia effort founded in 2011

More About this Source Visit The Verge